Safety and Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with High-Dose Oxaliplatin in Patients with Peritoneal Carcinomatosis

Background Cytoreduction with hyperthermic intraperitoneal chemoperfusion (HIPEC) has an established role in selected patients with peritoneal carcinomatosis (PC). We analyzed the safety and efficacy of HIPEC using high-dose oxaliplatin, a cytotoxic agent commonly used in metastatic colorectal cance...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2008-02, Vol.15 (2), p.535-541
Hauptverfasser:	Ceelen, Wim P., Peeters, Marc, Houtmeyers, Philippe, Breusegem, Christophe, De Somer, Filip, Pattyn, Piet
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Chemotherapy, Cancer, Regional Perfusion - adverse effects Combined Modality Therapy Female Gastrointestinal Neoplasms - pathology Gastrointestinal Oncology Humans Hyperthermia, Induced Injections, Intraperitoneal Length of Stay Liver - drug effects Male Medicine Medicine & Public Health Middle Aged Oncology Organoplatinum Compounds - administration & dosage Organoplatinum Compounds - adverse effects Ovarian Neoplasms - pathology Peritoneal Neoplasms - blood Peritoneal Neoplasms - drug therapy Peritoneal Neoplasms - mortality Peritoneal Neoplasms - secondary Surgery Surgical Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!